New stent graft under scrutiny for aortic repair in japan
NCT ID NCT07049913
First seen Jan 11, 2026 · Last updated Jun 22, 2026 · Updated 28 times
Summary
This study is checking how well a device called the GORE® TAG® Thoracic Branch Endoprosthesis works for people with a thoracic aortic aneurysm, dissection, or injury. About 200 patients in Japan who receive this stent graft will be followed to see if it is safe and effective. The main goals are to ensure the device can be placed successfully and to track any serious complications like stroke, paralysis, or device problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRAUMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The University of Osaka Hospital
RECRUITINGOsaka, Suita, 565-0871, Japan
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
GORE® TAG® Thoracic Branch Endoprosthesis (a stent graft device placed in the aorta to repair damage)
What this could lead to
If successful, this could confirm that the device is a safe and effective option for treating serious aortic conditions in the chest.
What could go wrong
This is a post-market surveillance study, not a randomized trial, so results may not apply to all patients. Risks include stroke, paralysis, kidney failure, or device complications.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.